Effects of Baclofen on Presynaptic Inhibition in Humans

Drug
General health
Online since 10 November 2021, updated 889 days ago

About this trial

This study examines the role of the GABA-B receptor in long-lasting presynaptic inhibition of primary afferents in human participants. Participants will come in for two visits, receiving baclofen (a G...

Included participants

Gender
All
Age
18 - 65 years
Injury level
Level not specified
  • Severity (AIS)?
  • AIS-A
    AIS-B
    AIS-C
    AIS-D
    Time since injury
    All
  • Injury type
  • Traumatic

    Non-traumatic

    Healthy volunteers
    Yes
    Level not specified

    What’s involved

    Type

    Drug

    Details

    There are no details yet

    Potential benefits

    Main benefits

    General health

    Additional benefits

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Ended
    • Trial start date
    • 10 Jan 2020
    • Organisation
    • University of Alberta
    • Trial recruitment status
    • Ended
    • Trial start date
    • 10 Jan 2020
    • Organisation
    • University of Alberta

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more